Clinical Trial Update: IAH0968 in Combination With GC for the Treatment of HER2-Positive Unresectable Advanced/Metastatic Malignant Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for IAH0968 in combination with GC for HER2-positive unresectable advanced/metastatic malignant tumors; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• IAH0968 (IAH0968)

Snippet

Sponsor: SUNHO（China）BioPharmaceutical CO., Ltd. | Conditions: HER2 Gene Mutation | Phase 1, Phase 2 | Status: UNKNOWN